General Principles for Evaluating the Abuse Deterrence of Generic Solid Oral Opioid Drug Products Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 21, 2017
April 21, 2020
16f7c065-5c32-47ae-b140-ebaacee129ac
Related Documents
Requests for Reconsideration at the Division Level Under GDUFA
Guidance DocumentOctober 16, 2024Center for Drug Evaluation and Research
Competitive Generic Therapies
Guidance DocumentOctober 5, 2022Center for Drug Evaluation and Research
Over-the-Counter Pediatric Oral Liquid Drug Products Containing Acetaminophen
Guidance DocumentAugust 5, 2015Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox